Day: September 11, 2023

Duck Creek Technologies Announces New Chief Financial Officer

Company appoints Teresa M. Kim, experienced technology finance executive, to oversee finance and accounting functions Duck Creek Technologies Announces New Chief Financial Officer BOSTON, Sept. 11, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, announces the appointment

WillScot Mobile Mini Announces $500 Million Senior Secured Notes Offering

PHOENIX, Sept. 11, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), the North American leader in innovative flexible space and storage solutions, today announced that its indirect subsidiary Williams Scotsman, Inc. (“WSI”) plans to offer, subject to market and other conditions,

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

– INNA-051 increased early expression of multiple antiviral effector genes compared with placebo and shortened viral shedding duration in participants with confirmed influenza infection MELBOURNE, Australia and MILAN, Italy, Sept. 11, 2023 (GLOBE NEWSWIRE) — ENA Respiratory, a clinical-stage pharmaceutical company, announced positive data from the Phase 2a flu challenge

Arbor Metals Commences Exploration at Jarnet Lithium Project, Quebec, Canada

Map of Arbor Metal Corp.’s Jarnet Lithium Claims VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Arbor Metals Corp. (“Arbor” or the “Company”) (TSXV: ABR, FWB: 432 is pleased to announce the deployment of its exploration team to the Company’s Jarnet lithium project in the James Bay region of

Samsung Bioepis Partners with Sandoz to Commercialize Ustekinumab Biosimilar Candidate

Enters into a commercialization agreement for SB17, ustekinumab biosimilar candidate, in Europe and North America Partnership to support Samsung Bioepis pipeline expansion and provide increased access to biosimilars INCHEON, Korea, Sept. 11, 2023 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. today announced that it has entered into a commercialization agreement